These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9268222

  • 1. Selectivity of BMS-180448 on myocardial versus brain blood flow in dogs and ferrets.
    Weselcouch EO, Gomoll AW.
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):61-8. PubMed ID: 9268222
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ, Grover GJ, Darbenzio RB, Sewter JC, Hess TA, Dzwonczyk S, Sleph PG.
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
    D'Alonzo AJ, Darbenzio RB, Sewter JC, Hess TA, Grover GJ, Sleph PG, Normandin DE, Lodge NJ.
    Eur J Pharmacol; 1995 Dec 27; 294(1):271-80. PubMed ID: 8788441
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ, D'Alonzo AJ, Garlid KD, Bajgar R, Lodge NJ, Sleph PG, Darbenzio RB, Hess TA, Smith MA, Paucek P, Atwal KS.
    J Pharmacol Exp Ther; 2001 Jun 27; 297(3):1184-92. PubMed ID: 11356945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
    Rhim BY, Lee WS, Hong KW.
    Jpn J Pharmacol; 1992 Jun 27; 58 Suppl 2():335P. PubMed ID: 1507584
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
    Grover GJ, Sleph PG.
    J Cardiovasc Pharmacol; 1995 Nov 27; 26(5):698-706. PubMed ID: 8637183
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR, Toombs CF, Khan SA, Buchanan LV, Cimini MG, Gibson JK, Meisheri KD, Shebuski RJ.
    Pharmacology; 1994 Aug 27; 49(2):86-95. PubMed ID: 7972325
    [Abstract] [Full Text] [Related]

  • 17. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB, Giardino EC, Salata JJ, Moore JB, Falotico R.
    J Pharmacol Exp Ther; 1993 Nov 27; 267(2):648-56. PubMed ID: 8246137
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W, Hirano Y, Taguchi T, Masuda N, Shirai Y, Satoh N, Takenaka T.
    Eur J Pharmacol; 1994 Nov 03; 264(3):285-93. PubMed ID: 7698167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF, la Rochelle CD, Berdeaux A.
    J Pharmacol Exp Ther; 1990 Nov 03; 255(2):836-42. PubMed ID: 2173761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.